Who Should Receive Extended Infusion Beta-Lactam Therapy?

Christopher T. Roman; Tia Sloth; Kendra M. Damer

doi:10.1097/01.JAA.0000480576.16121.88

Who Should Receive Extended Infusion Beta-Lactam Therapy?

Christopher T. Roman, Tia Sloth, Kendra M. Damer

Research output: Contribution to journal › Article › peer-review

Abstract

The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.

Original language	American English
Journal	Journal of the American Academy of Physician Assistants
Volume	29
DOIs	https://doi.org/10.1097/01.JAA.0000480576.16121.88
State	Published - Jan 1 2016

Keywords

beta-lactam therapy
case studies
antiobiotic resistance

Disciplines

Medicine and Health Sciences
Therapeutics

Access to Document

10.1097/01.JAA.0000480576.16121.88License: Unspecified

http://dx.doi.org/10.1097/01.JAA.0000480576.16121.88

Cite this

@article{1f9b50090ca844fda81a47025e7492ce,

title = "Who Should Receive Extended Infusion Beta-Lactam Therapy?",

abstract = " The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.",

keywords = "beta-lactam therapy, case studies, antiobiotic resistance",

author = "Roman, {Christopher T.} and Tia Sloth and Damer, {Kendra M.}",

year = "2016",

month = jan,

day = "1",

doi = "10.1097/01.JAA.0000480576.16121.88",

language = "American English",